UPMC Enterprises

UPMC Enterprises develops and invests in technology aimed at solving complex problems in health care. It is the innovation, commercialization, and venture capital arm of UPMC, a health care provider and insurer based in Pittsburgh, PA. The organization provides its portfolio companies and partners with capital, connections, and resources, and focuses on two areas: Translational Sciences and Digital Solutions. It also offers technology services including Ahavi™ data and analytics, strategic services, infrastructure and security services, and product acceleration services.

UPMC Enterprises is the innovation, commercialization, and venture capital arm of UPMC, a $28 billion health care provider and insurer based in Pittsburgh, PA. It develops and invests in technology that is helping to solve some of the hardest and most complex problems in health care. The organization taps the clinical acumen of more than 5,000 UPMC physicians and relies on payer perspectives from the UPMC Health Plan, which provides affordable, high-quality, value-based care to more than 4 million members. It invests financial and intellectual capital into developing solutions that benefit the entire health care industry, supporting both early and growth stage companies. When it invests in or forms a company, the Enterprises team becomes an integral part of that company, offering far more than just financial capital.

Innovation, commercialization, and venture capital arm of UPMC focused on health care technology.

• Ahavi™

  A real-world data platform developed by UPMC Enterprises to provide de-identified health care data to enable researchers, scientists, and developers to create curated datasets for accelerating research, clinical trial design, and AI development.

1. 1Home | UPMC Enterprisesenterprises.upmc.com
2. 2Technology Services | UPMC Enterprisesenterprises.upmc.com
3. 3Ahavi | UPMC Enterprisesenterprises.upmc.com
4. 4About | UPMC Enterprisesenterprises.upmc.com
5. 5Sempre Health Raises $15M in Series B Financing to Improve Medication Affordabilityprnewswire.com
6. 6Smile CDR Closes $20 Million in Series A Funding to Drive New Innovations in Clinical Data Managementprnewswire.com
7. 7SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officerbiospace.com
8. 8Werewolf Therapeutics Launches with $56M Series A Financing to Develop Transformative Immuno-Stimulatory Cancer Medicinesprnewswire.com